Animal experiments support the combination of the EP4 antagonist E7046 (ER0886046) with anti-CTLA4 in a mouse melanoma B16F10 model and with anti-PD-1 or anti-PD-L1 antibodies in a mouse colon cancer CT26 model. The gene discussed is PTGER4; the disease is malignant colon neoplasm.